380 related articles for article (PubMed ID: 25883167)
1. Technology to Reduce Hypoglycemia.
Yeoh E; Choudhary P
J Diabetes Sci Technol; 2015 Jul; 9(4):911-6. PubMed ID: 25883167
[TBL] [Abstract][Full Text] [Related]
2. Numerical and clinical precision of continuous glucose monitoring in Colombian patients treated with insulin infusion pump with automated suspension in hypoglycemia.
Gómez AM; Marín Sánchez A; Muñoz OM; Colón Peña CA
Endocrinol Nutr; 2015 Dec; 62(10):485-92. PubMed ID: 26531841
[TBL] [Abstract][Full Text] [Related]
3. The use of technology to reduce hypoglycemia.
Choudhary P; Amiel SA
Pediatr Endocrinol Rev; 2010 Aug; 7 Suppl 3():384-95. PubMed ID: 20877251
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity of the Predictive Hypoglycemia Minimizer System to the Algorithm Aggressiveness Factor.
Finan DA; Dassau E; Breton MD; Patek SD; McCann TW; Kovatchev BP; Doyle FJ; Levy BL; Venugopalan R
J Diabetes Sci Technol; 2015 Jun; 10(1):104-10. PubMed ID: 26134834
[TBL] [Abstract][Full Text] [Related]
5. Hypoglycemia prevention via pump attenuation and red-yellow-green "traffic" lights using continuous glucose monitoring and insulin pump data.
Hughes CS; Patek SD; Breton MD; Kovatchev BP
J Diabetes Sci Technol; 2010 Sep; 4(5):1146-55. PubMed ID: 20920434
[TBL] [Abstract][Full Text] [Related]
6. Continuous Glucose Monitoring, Future Products, and Update on Worldwide Artificial Pancreas Projects.
Kropff J; DeVries JH
Diabetes Technol Ther; 2016 Feb; 18 Suppl 2(Suppl 2):S253-63. PubMed ID: 26784131
[TBL] [Abstract][Full Text] [Related]
7. Sensor-Augmented Insulin Pumps and Hypoglycemia Prevention in Type 1 Diabetes.
Steineck I; Ranjan A; Nørgaard K; Schmidt S
J Diabetes Sci Technol; 2017 Jan; 11(1):50-58. PubMed ID: 28264173
[TBL] [Abstract][Full Text] [Related]
8. Perioperative Considerations for Evolving Artificial Pancreas Devices.
Long MT; Coursin DB; Rice MJ
Anesth Analg; 2019 May; 128(5):902-906. PubMed ID: 30198923
[TBL] [Abstract][Full Text] [Related]
9. Closed loop insulin delivery in diabetes.
Battelino T; Omladič JŠ; Phillip M
Best Pract Res Clin Endocrinol Metab; 2015 Jun; 29(3):315-25. PubMed ID: 26051293
[TBL] [Abstract][Full Text] [Related]
10. Multicenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive control in adults with type 1 diabetes.
Del Favero S; Place J; Kropff J; Messori M; Keith-Hynes P; Visentin R; Monaro M; Galasso S; Boscari F; Toffanin C; Di Palma F; Lanzola G; Scarpellini S; Farret A; Kovatchev B; Avogaro A; Bruttomesso D; Magni L; DeVries JH; Cobelli C; Renard E;
Diabetes Obes Metab; 2015 May; 17(5):468-76. PubMed ID: 25600304
[TBL] [Abstract][Full Text] [Related]
11. [From insulin pump and continuous glucose monitoring to the artificial pancreas].
Apablaza P; Soto N; Codner E
Rev Med Chil; 2017 May; 145(5):630-640. PubMed ID: 28898340
[TBL] [Abstract][Full Text] [Related]
12. IQWiG Reanalyzes and Raises Questions About an Article by Ly et al Which Concluded Low Glucose Suspend Is Very Beneficial.
Heinemann L; Hermanns N
J Diabetes Sci Technol; 2015 Aug; 10(1):185-90. PubMed ID: 26251370
[TBL] [Abstract][Full Text] [Related]
13. Continuous glucose monitoring and closed-loop systems.
Hovorka R
Diabet Med; 2006 Jan; 23(1):1-12. PubMed ID: 16409558
[TBL] [Abstract][Full Text] [Related]
14. Predictors of Hypoglycemia in the ASPIRE In-Home Study and Effects of Automatic Suspension of Insulin Delivery.
Weiss R; Garg SK; Bergenstal RM; Klonoff DC; Bode BW; Bailey TS; Thrasher J; Schwartz F; Welsh JB; Kaufman FR;
J Diabetes Sci Technol; 2015 May; 9(5):1016-20. PubMed ID: 25986629
[TBL] [Abstract][Full Text] [Related]
15. Diabetes technology and treatments in the paediatric age group.
Shalitin S; Peter Chase H
Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
[TBL] [Abstract][Full Text] [Related]
16. A cost-effectiveness analysis of sensor-augmented insulin pump therapy and automated insulin suspension versus standard pump therapy for hypoglycemic unaware patients with type 1 diabetes.
Ly TT; Brnabic AJ; Eggleston A; Kolivos A; McBride ME; Schrover R; Jones TW
Value Health; 2014 Jul; 17(5):561-9. PubMed ID: 25128049
[TBL] [Abstract][Full Text] [Related]
17. Modern clinical management helps reducing the impact of type 1 diabetes in children.
Scaramuzza AE; Zuccotti GV
Pharmacol Res; 2015 Aug; 98():16-21. PubMed ID: 25779986
[TBL] [Abstract][Full Text] [Related]
18. Semi-closed-loop insulin delivery systems: early experience with low-glucose insulin suspend pumps.
Pickup JC
Diabetes Technol Ther; 2011 Jul; 13(7):695-8. PubMed ID: 21668344
[No Abstract] [Full Text] [Related]
19. Continuous Glucose Monitoring: Review of an Innovation in Diabetes Management.
Mian Z; Hermayer KL; Jenkins A
Am J Med Sci; 2019 Nov; 358(5):332-339. PubMed ID: 31402042
[TBL] [Abstract][Full Text] [Related]
20. Implantable closed-loop glucose-sensing and insulin delivery: the future for insulin pump therapy.
Renard E
Curr Opin Pharmacol; 2002 Dec; 2(6):708-16. PubMed ID: 12482735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
